A Single-center, Pilot, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine in the Recovery of Hospitalized Patients With COVID-19
This pilot study is being performed to assess the efficacy and safety of inhaled ensifentrine delivered via pMDI compared with a matching placebo in conjunction with standard of care treatments on recovery in patients hospitalized due to COVID-19 infection.
100 项与 Verona Pharma, Inc. 相关的临床结果
0 项与 Verona Pharma, Inc. 相关的专利(医药)
100 项与 Verona Pharma, Inc. 相关的药物交易
100 项与 Verona Pharma, Inc. 相关的转化医学